Walter John H, White Fiona J
Willink Biochemical Genetics Unit, Royal Manchester Children's Hospital, Manchester, UK.
Int J Adolesc Med Health. 2004 Jan-Mar;16(1):41-5. doi: 10.1515/ijamh.2004.16.1.41.
In order to determine the degree of compliance with dietary treatment in adolescents with phenylketonuria (PKU) we have analysed blood phenylalanine (phe) results in 75 patients (42 male) aged between 10 and 20 years. We compared these results with the upper limit for blood phe and the blood sampling frequency as recommended by the United Kingdom's National Society for Phenylketonuria (NSPKU(UK)). The blood phe increased with age from a mean (1SD) of 0.51 mmol/l (0.19) at 10 years to 0.98 mmol/l (0.30) by 20 years. A mean of 17% (24) of samples were above the recommended range at 10 years, but this had increased to a mean of 75% (33) by 20 yrs. The frequency of blood sampling fell from a mean of 83% (32) of that recommended to under 51% (37) by 20 years. Control was not significantly better in females compared with males. We conclude that although compliance with treatment in PKU is acceptable for most patients at 10 years this is not the case by late adolescents and early adulthood.
为了确定苯丙酮尿症(PKU)青少年患者饮食治疗的依从程度,我们分析了75例年龄在10至20岁之间患者(42例男性)的血苯丙氨酸(phe)检测结果。我们将这些结果与英国苯丙酮尿症国家协会(NSPKU(UK))推荐的血phe上限及采血频率进行了比较。血phe水平随年龄增长,从10岁时的平均(标准差)0.51 mmol/l(0.19)增至20岁时的0.98 mmol/l(0.30)。10岁时平均有17%(24例)样本超出推荐范围,但到20岁时这一比例增至平均75%(33例)。采血频率从平均为推荐频率的83%(32次)降至20岁时的不足51%(37次)。女性患者的控制情况与男性相比并无显著更好。我们得出结论,虽然大多数PKU患者在10岁时治疗依从性尚可,但到青少年晚期和成年早期情况并非如此。